Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 324 results found. Search for [ sputnik V ]

Results 1 to 21 of 324
BusinessToday.In
February 24, 2021
Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week


BusinessToday.In
February 20, 2021
Russia has already approved two COVID-19 vaccines, Sputnik V and EpiVacCorona, which were also granted approval before seeing any late-stage trial results


BusinessToday.In
February 19, 2021
As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21st February 2021.


BusinessToday.In
February 17, 2021
Saying that vaccination is necessary to fight the pandemic, Guleria urged people to not be afraid of the vaccine as it is totally safe.


Reuters
February 17, 2021
Having reported the highest number of coronavirus infections after the United States, and with the world's biggest vaccine-making capacity, India says it has been the fastest to reach many inoculation milestones


BusinessToday.In
New Delhi, February 16, 2021
With no relief in sight from incessant rise in petrol and diesel prices, people turned to Twitter to vent their frustrations on the matter; The central government is set to notify the rules under new labour codes, which will have an impact on employees' cost to company (CTC) as well as employers' wage bills; Vaccination drive against COVID-19 and improving economic indicators have enthused employers to recruit. Watch this and more on News Blast.Also Read: Amazon to manufacture Fire TV Stick in India from this year


Rashi Bisaria
New Delhi, February 16, 2021
Revival in job market: January sees 50% rise in vacancies over December Vaccination drive against COVID-19 and improving economic indicators has enthused employers to recruit. This was evident in a survey which showed job openings increased almost 50 per cent in January as compared to December. Vacancies in January rose to 265,000 from 180,000 in December, according to Xpheno's Active Job Outlook survey. COVID-19 vaccine: Russia's Sputnik V may be approved by India in next few weeks Ind...


BusinessToday.In
February 16, 2021
Serum Institute has applied for registration with Health Canada with the help of Toronto-based Verity Pharmaceuticals, Adar Poonawalla said


PTI
February 16, 2021
Total 35 persons have been hospitalised after being administered a vaccine so far, which account for 0.0004 per cent of the total vaccinations


Chitranjan Kumar
February 15, 2021
COVID-19 vaccine: The AstraZeneca-Oxford product is a viral vectored vaccine called ChAdOx1-S [recombinant], which is being produced at several manufacturing sites, as well as in the Republic of Korea and India


BusinessToday.In
February 15, 2021
Earlier, Dr Reddy's had said it expects to roll out Sputnik V vaccine in India in March via Emergency Use Authorisation (EUA) after the completion of Phase 3 trials.


Reuters
February 12, 2021
In India, we are fortunate that supply of vaccines is not a rate-limiting step, but to meet the timelines set by the government, we will have to immunise somewhere between 4 and 5 times more people each day than we are doing today, says Gagandeep Kang of Christian Medical College in Vellore


Reuters
February 9, 2021
Just the two shots have been used in what India calls the world's biggest immunisation programme to cover 300 million people by August, starting with healthcare and other workers to reach the elderly and those with existing conditions by March


Reuters
February 9, 2021
Another candidate, developed by CanSino Biologics Inc(CanSinoBIO), has also completed clinical trials in the South Asian nation of 220 million people


PTI
February 6, 2021
External Affairs Minister S Jaishankar said some poor countries are being supplied the vaccine on a grant basis, while some nations wanted it on par with the price that the Indian government pays to the vaccine makers


BusinessToday.In
February 4, 2021
India boasts one of the biggest pharmaceutical industries globally and several countries have already approached it for procuring COVID-19 vaccines


Reuters
February 4, 2021
The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world


BusinessToday.In
February 3, 2021
Earlier, The Lancet had stated that Russia's experimental COVID-19 vaccine Sputnik V is 91.6 per cent affective against coronavirus infection. These results are based on Phase 3 trials of the vaccine in which 20,000 people had participated


BusinessToday.In
New Delhi, February 3, 2021
Russia's COVID-19 vaccine, Sputnik V, has shown 91.6 per cent efficacy in phase 3 trials with no serious side effects, as per an interim analysis published in The Lancet Journal; Oxford Languages has named 'Aatmanirbharta' as its Hindi Word of the Year 2020; Alibaba Group founder Jack Ma has been delisted from \"Chinese entrepreneurial leaders\" list published by the country's official state media. Watch this and more on News Blast. Also Read: RBI releases framework for risk-based internal audit of NBFCs, UCBs


PB Jayakumar
February 3, 2021
Bharat Biotech will supply initial doses to be used in the US upon Ocugen's receipt of an EUA from the US regulatory authorities


PAGES 1 OF 17  12345